HYDROCHLOROTHIAZIDE 50MG TABLETS 50 MG — DIN 02232653
HYDROCHLOROTHIAZIDE : 50 MG · LABORATOIRES CONFAB INC · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED PRE MARKET
What is HYDROCHLOROTHIAZIDE 50MG TABLETS?
HYDROCHLOROTHIAZIDE 50MG TABLETS 50 MG contains HYDROCHLOROTHIAZIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02232653, held by LABORATOIRES CONFAB INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 09-Apr-2021. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Hydrochlorothiazide in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
18 holders have a Canadian DIN containing Hydrochlorothiazide, across 53 DINs, of which 12 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| APOTEX INC | 4 | 3 | APO-HYDROCHLOROTHIAZIDE | Sourceable in Canada |
| PHARMASCIENCE INC | 4 | 3 | PMS-HYDROCHLOROTHIAZIDE | Sourceable in Canada |
| TEVA CANADA LIMITED | 4 | 2 | NTP-HYDROCHLOROTHIAZIDE, TEVA-HYDROCHLOROTHIAZIDE | Sourceable in Canada |
| MINT PHARMACEUTICALS INC | 3 | 2 | MINT-HYDROCHLOROTHIAZIDE | Sourceable in Canada |
| PRO DOC LIMITEE | 5 | 1 | HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE 100 TAB, HYDROCHLOROTHIAZIDE 50, HYDROCHLOROTHIAZIDE TAB 25MG | Sourceable in Canada |
| SANIS HEALTH INC | 2 | 1 | HYDROCHLOROTHIAZIDE | Sourceable in Canada |
| BIOMED PHARMA | 8 | 0 | BIO-HYDROCHLOROTHIAZIDE, DOM-HYDROCHLOROTHIAZIDE, UROZIDE | No marketed DIN |
| AVANSTRA INC | 3 | 0 | AVA-HYDROCHLOROTHIAZIDE | No marketed DIN |
| LABORATOIRES CONFAB INC | 3 | 0 | HYDROCHLOROTHIAZIDE 100MG TABLETS, HYDROCHLOROTHIAZIDE 25MG TABLETS, HYDROCHLOROTHIAZIDE 50MG TABLETS | No marketed DIN |
| MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | 3 | 0 | HYDRODIURIL TAB 100MG, HYDRODIURIL TAB 25MG, HYDRODIURIL TAB 50MG | No marketed DIN |
| NU-PHARM INC | 3 | 0 | NU-HYDRO | No marketed DIN |
| NEOLAB INC | 2 | 0 | NEO CODEMA 25MG, NEO CODEMA 50MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Hydrochlorothiazide |
|---|---|
| ATC code | C03AA03 |
| AHFS class | 40:28.20 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02232653 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2232653 |
| Brand name | HYDROCHLOROTHIAZIDE 50MG TABLETS |
| Generic / active ingredient | HYDROCHLOROTHIAZIDE : 50 MG |
| Market authorization holder | LABORATOIRES CONFAB INC |
| Health Canada schedule | Prescription |
| ATC code | C03AA03 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C03AA |
| Current status | CANCELLED PRE MARKET |
| Status date | 09-Apr-2021 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
12 of 53 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-HYDROCHLOROTHIAZIDE | 12.5 MG | TABLET | APOTEX INC | MARKETED | 02327856 |
| APO-HYDROCHLOROTHIAZIDE | 25 MG | TABLET | APOTEX INC | MARKETED | 00326844 |
| APO-HYDROCHLOROTHIAZIDE | 50 MG | TABLET | APOTEX INC | MARKETED | 00312800 |
| HYDROCHLOROTHIAZIDE | 25 MG | TABLET | SANIS HEALTH INC | MARKETED | 02360594 |
| HYDROCHLOROTHIAZIDE | 25 MG | TABLET | PRO DOC LIMITEE | MARKETED | 02486962 |
| MINT-HYDROCHLOROTHIAZIDE | 25 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | 02426196 |
| MINT-HYDROCHLOROTHIAZIDE | 12.5 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | 02425947 |
| PMS-HYDROCHLOROTHIAZIDE | 50 MG | TABLET | PHARMASCIENCE INC | MARKETED | 02247387 |
| PMS-HYDROCHLOROTHIAZIDE | 25 MG | TABLET | PHARMASCIENCE INC | MARKETED | 02247386 |
| PMS-HYDROCHLOROTHIAZIDE | 12.5 MG | TABLET | PHARMASCIENCE INC | MARKETED | 02274086 |
2 · Same class — other molecules in ATC C03AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Hydrochlorothiazide | APO-HYDROCHLOROTHIAZIDE · AVA-HYDROCHLOROTHIAZIDE · BIO-HYDROCHLOROTHIAZIDE · DIUCHLOR H TAB 50MG · +23 more | 53 | 12 | Yes |
| Bendroflumethiazide | NATURETIN 5MG | 1 | 0 | Not in Canada |
| Methyclothiazide | DURETIC 5MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is HYDROCHLOROTHIAZIDE 50MG TABLETS called?
The same molecule, Hydrochlorothiazide, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Hydromed | Latin | Iceland |
| HCT Parlogis | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Hydrochlorothiazide called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Hydrochlorothiazide, published to help those searches reach this page.
| Language | Hydrochlorothiazide |
|---|---|
| Arabic العربية | هيدروكلوروثيازيد |
| Chinese (Simplified) 简体中文 | 氢氯噻嗪 |
| Russian Русский | Гидрохлоротиазид |
| Spanish Español | Hidroclorotiazida |
| French Français | Hydrochlorothiazide |
| Portuguese Português | Hidroclorotiazida |
| Japanese 日本語 | ヒドロクロロチアジド |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.